Want to see JP:2796 full AI Analyst Report?
Pharmarise Holdings Corp. (2796) Income Statement
Pharmarise Holdings Corp. Income Statement
Last quarter (Q1 2026), Pharmarise Holdings Corp.'s total revenue was $17.24B, an increase of 2.92% from the same quarter last year. In Q1, Pharmarise Holdings Corp.'s net income was $-37.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | May 25 | May 24 | May 23 | May 22 | May 21 |
|---|---|---|---|---|---|
| $ 69.51B | $ 63.51B | $ 54.47B | $ 52.03B | $ 51.61B | |
| $ 8.64B | $ 8.20B | $ 7.89B | $ 7.50B | $ 7.42B | |
| $ 7.66B | $ 7.91B | $ 6.98B | $ 6.06B | $ 5.90B | |
| Depreciation and Amortization | $ 1.60B | $ 1.49B | $ 1.17B | $ 1.22B | $ 1.31B |
| $ 2.58B | $ 1.68B | $ 1.38B | $ 2.33B | $ 2.69B | |
| $ 980.00M | $ 295.00M | $ 916.00M | $ 1.44B | $ 1.52B | |
| $ -282.00M | $ -287.00M | $ -773.00M | $ -390.00M | $ -199.00M | |
| $ 698.00M | $ 8.00M | $ 143.00M | $ 1.05B | $ 1.32B | |
| $ 113.00M | $ -368.00M | $ -351.00M | $ 333.00M | $ 448.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ 9.95 | $ -32.42 | $ -33.35 | $ 35.42 | $ 47.90 |
| Diluted EPS | $ 9.56 | $ -32.42 | $ -33.35 | $ 26.86 | $ 36.22 |
| Weighted Average Shares Outstanding | 11.46M | 11.32M | 10.52M | 9.40M | 9.33M |
| Weighted Average Shares Outstanding (Diluted) | 11.92M | 11.32M | 10.52M | 12.47M | 12.40M |
Currency in JPY